Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Evaluation of the expression pattern and diagnostic value of PPARγ in malignant and benign primary bone tumors

Fig. 1

The assessed PPARγ mRNA expression levels in primary bone tumors. The mRNA expression level was evaluated in osteosarcoma, Ewing Sarcoma and GCT tumors. The mRNA expression level of PPARγ was increased in bone tumor (a) versus tumor margins also in malignant tumors versus benign tumors (b). The elevated level of PPARγ was detected in osteosarcoma and Ewing Sarcoma compared to their paired non-cancerous tissues (c). The statistical differences between groups are shown as asterisk (*= P < 0.05, **= P < 0.01, ****= P < 0.0001)

Back to article page